Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Oncology
Metadata
Title
Correction to: Cardiotoxicity of Systemic Melanoma Treatments
Authors
Neha Mukunda, MD
Srilakshmi Vallabhaneni, MD
Benedicte Lefebvre, MD
Michael G. Fradley, MD
Publication date
29-06-2022
Publisher
Springer US
Keywords
Melanoma
Melanoma
Published in
Current Treatment Options in Oncology / Issue 8/2022
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI
https://doi.org/10.1007/s11864-022-00992-y

Other articles of this Issue 8/2022

Current Treatment Options in Oncology 8/2022 Go to the issue

Leukemia (PH Wiernik, Section Editor)

How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia

Lower Gastrointestinal Cancers (AB Benson, Section Editor

The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies

Lung Cancer (TA Leal and N Sethakorn, Section Editors)

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Head and Neck Cancer (PL Swiecicki, Section Editor)

Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments

Gynecologic Cancers (JS Ferriss, Section Editor)

Incorporating Molecular Diagnostics into Treatment Paradigms for Endometrial Cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits